Featured News

Contact your Members of Congress and urge them to protect the Medicaid program. Celiac Disease Foundation is proud to join with the Modern Medicaid Alliance on their Medicaid Works campaign to help ensure that Americans can get affordable access to care. The Modern Medicaid Alliance is a group of organizations, grassroots advocates, and Medicaid beneficiaries…

Growing up, Skylar Weitz was self-conscious and shy about having celiac disease – she didn’t like feeling different from her peers. Today, at 11 years old, five years after her diagnosis, Skylar is proud to educate people about her disease and about how it affects a patient’s everyday life. In order to help raise awareness…

A research study published in the journal, Science, may have established a link between reovirus and celiac disease. Although reovirus is considered a common and often harmless virus, the study, co-authored by CDF Medical Advisory Board member, Stefano Guandalini, MD, and CDF Research Committee member, Sonia Kupfer, MD, determined that the reovirus, T1L, in some cases, might be causing the immune system to attack harmless food molecules, like gluten, triggering celiac disease.

A research study published in the journal, Science, may have established a link between reovirus and celiac disease. Although reovirus is considered a common and often harmless virus, the study, co-authored by CDF Medical Advisory Board member, Stefano Guandalini, MD, and CDF Research Committee member, Sonia Kupfer, MD, determined that the reovirus, T1L, in some cases,…

23andMe has been approved by the FDA to offer direct-to-consumer genetic screening for a number of diseases, including celiac disease. Consumers are strongly cautioned to consult their physician

Celiac Disease Foundation welcomes the FDA announcement that 23andMe can offer accessible, lower-cost, direct-to-consumer genetic screening for a number of diseases, including celiac disease. Celiac disease is a serious, genetic, autoimmune disorder caused by an immune reaction to the ingestion of gluten. Although it is often thought of as a rare disease, researchers tell us…

Celiac Disease Foundation is pleased to announce the release of Gluten-Free Marketplace 2.0, our completely updated, one-stop destination to search for all of your favorite gluten-free products, services, companies, and recipes. The Gluten-Free Marketplace is available at celiac.org/marketplace and as an app for iPhone and Android. Marketplace 2.0 showcases products and services from companies that…

Celiac Disease Foundation is pleased to announce the release of Gluten-Free Marketplace 2.0, our completely updated, one-stop destination to search for all of your favorite gluten-free products, services, companies, and recipes. The Gluten-Free Marketplace is available at celiac.org/marketplace and as an app for iPhone and Android. Marketplace 2.0 showcases products and services from companies that…

A year has passed since Celiac Disease Foundation launched its patient registry, iCureCeliac®. Since our launch, 2,300 participants have contributed their medical information and experiences living with celiac disease and non-celiac wheat/gluten sensitivity. This information will help researchers to better understand, develop treatments for, and ultimately cure celiac disease. Based on our recent data analysis…

ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease…